PRECEPT 66-2232

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 1999-12-14 for PRECEPT 66-2232 manufactured by Fortunique/ Guangzhou Fortunique, Ltd..

Event Text Entries

[206067] Complaint of irritation at an in-serve eval. Primary skin irritation studies were performed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1018223-1999-00001
MDR Report Key260532
Report Source07
Date Received1999-12-14
Date of Report1999-12-07
Date of Event1999-11-09
Date Mfgr Received1999-11-09
Date Added to Maude2000-02-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactMALINDA GRAVES
Manufacturer Street*
Manufacturer CityARDEN NC 28704
Manufacturer CountryUS
Manufacturer Postal28704
Manufacturer Phone8004526964
Manufacturer G1FORTUNIQUE/ GUANGZHOU FORTUNIQUE, LTD.
Manufacturer Street3/FB. NO. 18 TIAHEGAN XIANLIE ZHONG ROAD
Manufacturer CityGUANGZHOU 510070
Manufacturer CountryCH
Manufacturer Postal Code510070
Single Use3
Remedial ActionRL
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePRECEPT
Generic NameBOUFFANT CAP
Product CodeFYF
Date Received1999-12-14
Model Number66-2232
Catalog Number66-2232
Lot Number990321
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key252339
ManufacturerFORTUNIQUE/ GUANGZHOU FORTUNIQUE, LTD.
Manufacturer Address3/FB. NO. 18 TIAHEGAN XIANLIE ZHONG ROAD GUANGZHOU CH 510070
Baseline Brand NamePRECEPT
Baseline Generic NameBOUFFANT CAP
Baseline Model No66-2232
Baseline Catalog No66-2232
Baseline IDLOT # 990321
Baseline Device FamilyBOUFFANT CAPS
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNN
Baseline PreamendmentY
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Other 1999-12-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.